文献速递其他结缔组织病

基于循环免疫细胞生物物理表型鉴定系统性硬化症中单核细胞驱动的独特特征

Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells.
PubMed 文献 · Arthritis Rheumatol · 2023-03-20

该研究对63例系统性硬化症(SSc)患者、59例类风湿关节炎(RA)患者、28例抗中性粒细胞胞质抗体相关血管炎(AAV)患者及22名年龄性别匹配的健康供者行循环免疫细胞的实时荧光与变形性细胞术(RT-FDC)生物物理表型分析。结果发现SSc患者存在以单核细胞驱动的独特生物物理特征,该特征在RA和AAV中缺失,反映SSc特异性单核细胞活化而非一般性炎症。单核细胞生物物理特性与当前疾病活动度、皮肤或肺纤维化范围、微血管损伤表现严重程度及疾病进展风险相关。

要点

  • SSc患者循环免疫细胞存在以单核细胞驱动的独特生物物理特征。
  • 该特征在RA和AAV中缺失,反映SSc特异性单核细胞活化而非一般炎症。
  • 单核细胞生物物理特性与疾病活动度、纤维化范围、微血管损伤及进展风险相关。

核心结论

  • 循环免疫细胞生物物理特性的变化反映SSc患者病理性免疫细胞活化,并与临床结局相关。
  • 基于RT-FDC的单核细胞生物物理表型分析可作为评估SSc患者和进行风险分层的工具。

研究设计与样本

  • 对63例SSc患者、59例RA患者、28例AAV患者和22名年龄与性别匹配的健康供者行循环免疫细胞实时荧光与变形性细胞术(RT-FDC)生物物理表型分析。

主要发现

  • 鉴定出SSc患者循环免疫细胞生物物理特性的特定特征,该特征主要由单核细胞驱动。
  • 该特征在RA和AAV中缺失,反映SSc特异性单核细胞活化而非一般性炎症。
  • 单核细胞生物物理特性指示SSc患者当前疾病活动度、皮肤或肺纤维化范围、微血管损伤表现严重程度以及疾病进展风险。

临床怎么用

  • RT-FDC为基础的单核细胞生物物理表型分析可作为评估SSc患者和进行风险分层的工具。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pathologically activated circulating immune cells, including monocytes, play major roles in systemic sclerosis (SSc). Their functional characterization can provide crucial information with direct clinical relevance. However, tools for the evaluation of pathologic immune cell activation and, in general, of clinical outcomes in SSc are scarce. Biophysical phenotyping (including characterization of cell mechanics and morphology) provides access to a novel, mostly unexplored layer of information regarding pathophysiologic immune cell activation. We hypothesized that the biophysical phenotyping of circulating immune cells, reflecting their pathologic activation, can be used as a clinical tool for the evaluation and risk stratification of patients with SSc. METHODS: We performed biophysical phenotyping of circulating immune cells by real-time fluorescence and deformability cytometry (RT-FDC) in 63 SSc patients, 59 rheumatoid arthritis (RA) patients, 28 antineutrophil cytoplasmic antibody-associated vasculitis (AAV) patients, and 22 age- and sex-matched healthy donors. RESULTS: We identified a specific signature of biophysical properties of circulating immune cells in SSc patients that was mainly driven by monocytes. Since it is absent in RA and AAV, this signature reflects an SSc-specific monocyte activation rather than general inflammation. The biophysical properties of monocytes indicate current disease activity, the extent of skin or lung fibrosis, and the severity of manifestations of microvascular damage, as well as the risk of disease progression in SSc patients. CONCLUSION: Changes in the biophysical properties of circulating immune cells reflect their pathologic activation in SSc patients and are associated with clinical outcomes. As a high-throughput approach that requires minimal preparations, RT-FDC-based biophysical phenotyping of monocytes can serve as a tool for the evaluation and risk stratification of patients with SSc.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Matei AE, Kubánková M, Xu L, et al. Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells. Arthritis Rheumatol. 2023. PMID: 36281753. doi:10.1002/art.42394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。